Eucrates Biomedical Acquisition Corp.
EUCR · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|
| Market Cap | $30 | $29 | $135 |
| - Cash | $0 | $0 | $1 |
| + Debt | $0 | $0 | $0 |
| Enterprise Value | $30 | $29 | $135 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$3 | -$5 | $0 |
| % Margin | – | – | – |
| Net Income | $6 | $4 | $0 |
| % Margin | – | – | – |
| EPS Diluted | 1.86 | 0.28 | 0.001 |
| % Growth | 564.3% | 46,566.7% | – |
| Operating Cash Flow | -$1 | -$1 | – |
| Capital Expenditures | $0 | $0 | – |
| Free Cash Flow | -$1 | -$1 | – |